April 1, 2024

NRG Oncology Broadcast archives are accessible from our website at any time. Please bookmark this link for your convenience.

OTHER PROTOCOL NOTICES

1. ALL DISEASE SITES

NRG-GY022: Reminder: Actively Recruiting MALE Patients only Read More

2. BIOSPECIMEN BANK

Printing Biospecimen Transmittal PDFs from Rave

Please note an effort is underway to clarify how to obtain a Biospecimen Transmittal PDF for submission to the NRG Oncology Biospecimen Bank. Read More

3. BREAST

NRG-BR003: Call for submission of data and supporting documentation. Refer to the memo, dated March 25, 2024, posted on CTSU.

NRG-BR007/DEBRA: Study overview webinars are being held via Microsoft Teams on April 19 from 2-3pm ET and April 26 from 12-1pm ET. Please see the memorandum, dated March 25, 2024, (posted on CTSU) for details and how to register for one of the sessions. Please note: Google Chrome is the preferred browser to register for the webinars. 

NRG-BR008/HERO: Study overview webinars are being held via Microsoft Teams on April 30 at 3pm ET and May 1 at 11am ET. Please see the memorandum, dated April 1, 2024, (posted on CTSU) for details and how to register for one of the sessions. Please note: Google Chrome is the preferred browser to register for the webinars.

4. CANCER PREVENTION & CONTROL

NRG-CC010: The study is now open to NRG sites in Japan and South Korea. The optional biospecimen collection does not apply to sites participating in these countries.

5. GYNECOLOGIC

EAY191-N4 (ComboMATCH): Appendix XI, Section II, 1^st bullet: Reports should be REDACTED. Section 10.2: Footnote 2 will be deleted. These changes will be made with the next amendment.

GOG-0210: Reminder: Biospecimens, biomarker data, clinical data, and epidemiologic data are available for request. Please visit the NRG Oncology website for more information on this important study with the overall goal of improving the outcome and/or quality of life for patients with endometrial cancer.

NRG-GY031: Please note, there is an error in the section 4.2 table and the Biospecimen Collection and Submission Manual. The Part I PK collection is to be done on Cycle 1, Day 1, and Cycle 1, Day 8. This will be updated with the next amendment.

6. HEAD & NECK

NRG-HN008: Reminder - please update treatment and AE data weekly. This is a Phase I trial and timely data submission is very important. 

7. VTOC TRAINING

The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on NRG-HN001, NRG-HN002, NRG-CC003, NRG-CC005, NRG-BR009, NRG-CC011, and NRG/SWOG S1914. Space is limited so register now and reserve your seat. The next webinar training is scheduled for Wednesday, April 10, 2024.

DRUG SAFETY REPORTS

1. Annual Call for NRG Oncology Administrative Committee Member Applications

If you are interested in serving on an NRG Oncology administrative committee, or if you are a member who had previously served on a committee and would like to re-engage, please consider applying by April 4, 2024. Click here for instructions and application

2. Developing and Running an R01 Through NRG NCORP – Register for the webinar to be held on Thursday, April 11, 1 – 2:30pmET.

Participants will learn about the NRG NCORP concept review process with a specific focus on R01s.

Dr. Von Ah and Dr. Sikorskii will present their recent experiences developing R01s through the NRG NCORP, along with lessons learned and benefits of utilizing the NRG NCORP process. A panel of professionals will also be available to discuss their experiences and answer questions from attendees. The flyer with agenda can be found here.

Register in advance for this meeting.

https://us02web.zoom.us/meeting/register/tZEvdOitqjoqH9Bb2h67VHRdD_WlX-RyDgeZ

After registering you will receive an email with the meeting link.

3. NRG Oncology Confidential Member Survey

Please read our survey FAQ’s. All NRG Members should have received an email from the University of Chicago’s Survey Lab containing a unique survey link. If you have not already completed the survey, please check your inbox and possibly your spam/junk mailbox for the email so that you can help us collect this important information. Please send any additional questions to nrg-broadcasts@nrgoncology.org.

4. Health Disparities Committee Symposium

The NRG Oncology Health Disparities Committee (HDC) will be hosting their annual symposium on Tuesday, April 16, 2024; 3-4:30pm ET. The focus of this year’s symposium will be “Aligning Clinical Trial Development with an Aging Population: Challenges and Opportunities for Older Adults with Cancer.” Refer to the agenda or the flyer for details. Please register in advance for this webinar. After registering, you will receive an email with the webinar link.

5. Membership Reminders: Please take a moment to review and update your site person rosters!

NRG Oncology Members are required to designate individuals to fill the NRG Oncology Primary Roles. Primary Roles are:

• Check Addressee
• Contact PI
• LAPS PI
• Lead RA
• Co-Lead RA (optional)
• Local Lead RA
• Principal Investigators (A maximum of 3 and the contact PI is counted as 1)

These roles are used to communicate with respect to NRG Oncology studies and other important information. In order for a person to be assigned a Primary Role, he/she must have an active CTEP ID and be listed on the site's NRG Oncology Roster for the specific institution. A completed NRG Primary Role Change Form (located on NRG Oncology website, under Membership) must be submitted to roster@nrgoncology.org for any Primary Role changes.

The Roster Update Management System (RUMS) allows authorized people at clinical sites to manage roster data for secondary roles using a web-based application. Authorized persons can use RUMS to manage person secondary roles, to request the addition or withdrawal of persons to their associated clinical sites, and to request the addition or withdrawal of child sites from their local network. NCORP authorized users should request rostering of NCORP sites, investigators, and research associates via NCORP-SYS. A person must be rostered before any roles may be requested in RUMS. 

Required secondary roles are Local PI, Contract Contact, Fiscal Contact

Please take a moment and review your roster using RUMS or NCORP-SYS as applicable to ensure all of your network personnel are up to date. Contact roster@nrgoncology.org for assistance.

REMINDER: Any manuscript or abstract resulting from research done under the auspices of our NCI grant awards must be processed through the NRG Publications Office before being submitted to the journal or association. Please remember to cite any pertinent grant numbers in these publications.

Please note the following upcoming meetings and abstract submission deadlines

UPCOMING MEETINGS

American Association for Cancer Research (AACR); Apr 5-10, 2024; San Diego, CA

American Association for Thoracic Surgery (AATS); Apr 27-30, 2024; Toronto, ON

American Brachytherapy Society (ABS) World Congress; Jul 10-13, 2024; National Harbor, MD

American College of Radiology (ACR); Apr 13-17, 2024; Washington, DC

American Head and Neck Society (AHNS); May 15-16, 2024; Chicago, IL

American Radium Society (ARS); May 2-5, 2024; Palm Springs, CA

American Society of Breast Surgeons (ABS); Apr 10-14, 2024; Orlando, FL

American Society of Clinical Oncology (ASCO); May 31-Jun 4, 2024; Chicago, IL

American Society of Colon and Rectal Surgeons (ASCRS); Jun 1-4, 2024; Baltimore, MD

European Society for Medical Oncology (ESMO) Breast Cancer; May 15-17, 2024; Berlin, Germany

European Society for Radiotherapy and Oncology (ESTRO); May 3-7, 2024; Glasgow, Scotland

Society for Clinical Trials (SCT); May 19-22, 2024; Boston, MA

Western Association of Gynecologic Oncologists (WAGO); Jun 12-15, 2024; Seattle, WA

UPCOMING ABSTRACT SUBMISSION DEADLINES

American Society for Radiation Oncology (ASTRO); Sep 29-Oct 2, 2024; Washington, DC; LBA Jul 12, 2024

EORTC-NCI-AACR Symposium on Molecular Targets and therapies; Oct 23-25, 2024; Barcelona, Spain; due to publications committee Jun 13, 2024; submission deadline Jun 27, 2024; LBA Sep 26, 2024

European Society for Medical Oncology (ESMO); Sep 13-17, 2024; Barcelona, Spain; due to publications committee Apr 23, 2024; submission deadline May 7, 2024, 21:00 CET; LBA Aug 7, 2024, 21:00 CET (placeholder required)

European Society for Medical Oncology (ESMO) Gastrointestinal; Jun 26-29, 2024; Munich, Germany; submission deadline Apr 9, 2024, 21:00 CET; LBA Jun 6, 2024, 21:00 CET (placeholder required)

European Society for Medical Oncology (ESMO) Gynaecological; Jun 20-22, 2024; Florence, Italy; submission deadline Apr 3, 2024, 21:00 CET

International Society for Quality-of-Life Research (ISOQOL); Oct 13-16, 2024; Cologne, Germany; due to publications committee Mar 25, 2024; submission deadline Apr 8, 2024, CET

International Gynecologic Cancer Society (IGCS); Oct 16-18, 2024; Dublin, Ireland; due to publications committee Apr 16; submission deadline Apr 30, 2024, 23:59 IST; LBA Jul 2, 2024, 23:59 IST

Society for Immunotherapy of Cancer (SITC); Nov 6-10, 2024; Houston, TX; due to publications committee May 15, 2024; submission deadline Jun 27, 2024